Invasive Escherichia coli are a feature of Crohn's disease

Fiocchi, 1998, Inflammatory bowel disease: etiology and pathogenesis, Gastroenterology, 115, 182, 10.1016/S0016-5085(98)70381-6 Hendrickson, 2002, Clinical aspects and pathophysiology of inflammatory bowel disease, Clin Microbiol Rev, 15, 79, 10.1128/CMR.15.1.79-94.2002 Rogler, 1998, Cytokines in inflammatory bowel disease, World J Surg, 22, 382, 10.1007/s002689900401 Akazawa, 2002, Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase, J Gastroenterol, 37, 345, 10.1007/s005350200048 McCormack, 2001, Tissue cytokine and chemokine expression in inflammatory bowel disease, Inflamm Res, 50, 491, 10.1007/PL00000223 Mitsuyama, 1994, IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease, Clin Exp Immunol, 96, 432, 10.1111/j.1365-2249.1994.tb06047.x Tracey, 1994, Tumor necrosis factor: a pleiotropic cytokine and therapeutic target, Annu Rev Med, 45, 491, 10.1146/annurev.med.45.1.491 Miki, 1998, The sugar permeability test reflects disease activity in children and adolescents with inflammatory bowel disease, J Pediatr, 133, 750, 10.1016/S0022-3476(98)70145-3 Tibble, 2000, Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease, Gastroenterology, 119, 15, 10.1053/gast.2000.8523 D'Haens, 1998, Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum, Gastroenterology, 114, 262, 10.1016/S0016-5085(98)70476-7 Seo, 1999, The role of total parenteral nutrition in the management of patients with acute attacks of inflammatory bowel disease, J Clin Gastroenterol, 29, 270, 10.1097/00004836-199910000-00009 Sartor, 2004, Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics, Gastroenterology, 126, 1620, 10.1053/j.gastro.2004.03.024 Duchmann, 1995, Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD), Clin Exp Immunol, 102, 448, 10.1111/j.1365-2249.1995.tb03836.x Boudeau, 1999, Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease, Infect Immun, 67, 4499, 10.1128/IAI.67.9.4499-4509.1999 Glasser, 2001, Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death, Infect Immun, 69, 5529, 10.1128/IAI.69.9.5529-5537.2001 Donnenberg, 1990, A comparison of HEp-2 cell invasion by enteropathogenic and enteroinvasive Escherichia coli, FEMS Microbiol Lett, 57, 83, 10.1111/j.1574-6968.1990.tb04179.x Mobley, 1990, Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains, Infect Immun, 58, 1281, 10.1128/iai.58.5.1281-1289.1990 Taylor, 1988, Clinical and microbiologic features of Shigella and enteroinvasive Escherichia coli infections detected by DNA hybridization, J Clin Microbiol, 26, 1362, 10.1128/jcm.26.7.1362-1366.1988 Tzipori, 1987, Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets, Infect Immun, 55, 3117, 10.1128/iai.55.12.3117-3125.1987 Donnenberg, 1989, Epithelial cell invasion: an overlooked property of enteropathogenic Escherichia coli (EPEC) associated with the EPEC adherence factor, J Infect Dis, 160, 452, 10.1093/infdis/160.3.452 Nataro, 1995, Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers, J Infect Dis, 171, 465, 10.1093/infdis/171.2.465 Ribot, 2006, Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, SalmonellaShigella for PulseNet, Foodborne Pathog Dis, 3, 59, 10.1089/fpd.2006.3.59 Jung, 1995, A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion, J Clin Invest, 95, 55, 10.1172/JCI117676 Katz, 1989, Intestinal permeability in patients with Crohn's disease and their healthy relatives, Gastroenterology, 97, 927, 10.1016/0016-5085(89)91499-6 Gassler, 2001, Inflammatory bowel disease is associated with changes of enterocytic junctions, Am J Physiol Gastrointest Liver Physiol, 281, G216, 10.1152/ajpgi.2001.281.1.G216 Blair, 2006, Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease, Lab Invest, 86, 191, 10.1038/labinvest.3700373 Darfeuille-Michaud, 2004, High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease, Gastroenterology, 127, 412, 10.1053/j.gastro.2004.04.061 Keighley, 1978, Influence of inflammatory bowel disease on intestinal microflora, Gut, 19, 1099, 10.1136/gut.19.12.1099 Neut, 2002, Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease, Am J Gastroenterol, 97, 939, 10.1111/j.1572-0241.2002.05613.x Martinez-Medina, 2006, Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis, Inflamm Bowel Dis, 12, 1136, 10.1097/01.mib.0000235828.09305.0c Ryan, 2004, Bacterial DNA within granulomas of patients with Crohn's disease—detection by laser capture microdissection and PCR, Am J Gastroenterol, 99, 1539, 10.1111/j.1572-0241.2004.40103.x Cartun, 1993, An immunocytochemical search for infectious agents in Crohn's disease, Mod Pathol, 6, 212 Kotlowski, 2006, High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease, Gut, 13, 675 Fujita, 2002, Quantitative analysis of bacterial DNA from Mycobacteria spp. Bacteroides vulgatus, and Escherichia coli in tissue samples from patients with inflammatory bowel diseases, J Gastroenterol, 37, 509, 10.1007/s005350200079 Mylonaki, 2005, Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease, Inflamm Bowel Dis, 11, 481, 10.1097/01.MIB.0000159663.62651.4f Barnich, 2003, Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn's disease, Mol Microbiol, 48, 781, 10.1046/j.1365-2958.2003.03468.x Barnich, 2004, Involvement of lipoprotein NlpI in the virulence of adherent invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease, Infect Immun, 72, 2484, 10.1128/IAI.72.5.2484-2493.2004 Bringer, 2005, HtrA stress protein is involved in intramacrophagic replication of adherent and invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease, Infect Immun, 73, 712, 10.1128/IAI.73.2.712-721.2005 Martin, 2004, Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer, Gastroenterology, 127, 80, 10.1053/j.gastro.2004.03.054 Simpson, 2006, Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs, Infect Immun, 74, 4778, 10.1128/IAI.00067-06 Laffineur, 1992, Bacterial translocation in Crohn's disease, Gastroenterol Clin Biol, 16, 777 Ambrose, 1984, Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn's disease surgery, Br J Surg, 71, 623, 10.1002/bjs.1800710821 Swidsinski, 2002, Mucosal flora in inflammatory bowel disease, Gastroenterology, 122, 44, 10.1053/gast.2002.30294 Swidsinski, 2005, Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease, J Clin Microbiol, 43, 3380, 10.1128/JCM.43.7.3380-3389.2005 Abreu, 2005, TLR signaling in the gut in health and disease, J Immunol, 174, 4453, 10.4049/jimmunol.174.8.4453 Canto, 2006, TNF alpha production to TLR2 ligands in active IBD patients, Clin Immunol, 119, 156, 10.1016/j.clim.2005.12.005 Hausmann, 2002, Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation, Gastroenterology, 122, 1987, 10.1053/gast.2002.33662 Jarnerot, 2005, Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study, Gastroenterology, 128, 1805, 10.1053/j.gastro.2005.03.003 Rutgeerts, 2005, Infliximab for induction and maintenance therapy for ulcerative colitis, N Engl J Med, 353, 2462, 10.1056/NEJMoa050516 Hanauer, 2002, Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial, Lancet, 359, 1541, 10.1016/S0140-6736(02)08512-4 Targan, 1997, A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group, N Engl J Med, 337, 1029, 10.1056/NEJM199710093371502 Haraga, 2003, A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-kappa B-dependent gene expression, Infect Immun, 71, 4052, 10.1128/IAI.71.7.4052-4058.2003 Collier-Hyams, 2002, Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway, J Immunol, 169, 2846, 10.4049/jimmunol.169.6.2846 Zhou, 2004, Yersinia YopJ inhibits pro-inflammatory molecule expression in human bronchial epithelial cells, Respir Physiol Neurobiol, 140, 89, 10.1016/j.resp.2003.12.003 Daig, 1996, Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease, Gut, 38, 216, 10.1136/gut.38.2.216 Hollander, 1986, Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor, Ann Intern Med, 105, 883, 10.7326/0003-4819-105-6-883 Kucharzik, 2001, Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins, Am J Pathol, 159, 2001, 10.1016/S0002-9440(10)63051-9 Ye, 2006, Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier, Am J Physiol Gastrointest Liver Physiol, 290, G496, 10.1152/ajpgi.00318.2005 Darfeuille-Michaud, 1998, Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease, Gastroenterology, 115, 1405, 10.1016/S0016-5085(98)70019-8